Printer Friendly

Kids getting umbilical cord blood instead of BMT from HLA-identical siblings have lower GVHD.

Children who received umbilical cord blood transplants from HLA-identical siblings had a lower incidence of acute and chronic graft-versus-host disease (GVHD) than youngsters given bone marrow transplants (BMT) from HLA-identical siblings, according to an international study published in the June 22 issue of the New England Journal of Medicine.

Overall survival in this registry study of 113 cord blood recipients and 2,052 BMT recipients during the period from 1990 through 1997 did not differ significantly between the 2 groups, however, regardless of the indication for transplantation and despite a slower rate of engraftment after cord blood transplant.

"These results justify the systematic collection of cord blood in families with a child affected by a disease that can be treated successfully by allogeneic transplantation of hematopoietic stem cells," wrote Vanderson Rocha, MD and colleagues from the Eurocord-Cord Blood Transplant Group. "The results also support further exploration of cord blood as a source of stem cells for transplants from unrelated donors."
COPYRIGHT 2000 Transplant Communications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:Kids getting umbilical cord blood instead of BMT from HLA-identical siblings have lower GVHD.
Publication:Transplant News
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 30, 2000
Words:160
Previous Article:Gene transfer may repair salivary glands damaged by radiation therapy.
Next Article:FDA approves Novartis' Apligraf for treatment of diabetic foot ulcers.
Topics:


Related Articles
Umbilical cords as source of new blood.
A primer on placental blood banking.
BMT from related donor is life-saving treatment for SCIDs, study finds.
Bacterial decontamination reduces GVHD in patients receiving BMTs, study finds.
Reducing standard cyclosporine dose in children with acute leukemia receiving BMT lowers relapse risk.
Umbilical cord blood alternative source for hemotopoietic stem cells for adults, study finds.
GVHD more common after peripheral stem cell transplantation than BMT.
Slight mismatches do not increase risk of BMT failure inpatients with leukemia.
New methods for improving mismatched BMT success rates.
Unrelated BMT can be effective for ALL in second remission.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |